Luke W Arbogast1, Robert G Brinson1, Trina Formolo2, J Todd Hoopes1, John P Marino3. 1. Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology and the University of Maryland, 9600 Gudelsky Drive, Rockville, Maryland, 20850, USA. 2. National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, Maryland, 20899, USA. 3. Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology and the University of Maryland, 9600 Gudelsky Drive, Rockville, Maryland, 20850, USA. john.marino@nist.gov.
Abstract
PURPOSE: High-resolution nuclear magnetic resonance spectroscopy (NMR) provides a robust approach for producing unique spectral signatures of protein higher order structure at atomic resolution. Such signatures can be used as a tool to establish consistency of protein folding for the assessment of monoclonal antibody (mAb) drug quality and comparability. METHODS: Using the NIST monoclonal antibody (NISTmAb) and a commercial-sourced polyclonal antibody, both IgG1κ isotype, we apply 2D NMR methods at natural abundance for the acquisition and unbiased statistical analysis of (1)H(N) -(15)N correlated spectra of intact antibody (Ab) and protease-cleaved Fab and Fc fragments. RESULTS: The study demonstrates the feasibility of applying 2D NMR techniques to Abs and the precision with which these methods can be used to map structure and establish comparability between samples at atomic resolution. CONCLUSIONS: The statistical analyses suggests that, within the limit of detection, no significant structural differences are observed between the Fab and Fc domains of each respective intact Ab and its corresponding fragments. Discrimination between dissimilar species, such as between the Fab domains of both Abs or between the glycosylated and deglycosylated Fc domains, was further demonstrated. As such, these methods should find general utility for the assessment of mAb higher order structure.
PURPOSE: High-resolution nuclear magnetic resonance spectroscopy (NMR) provides a robust approach for producing unique spectral signatures of protein higher order structure at atomic resolution. Such signatures can be used as a tool to establish consistency of protein folding for the assessment of monoclonal antibody (mAb) drug quality and comparability. METHODS: Using the NIST monoclonal antibody (NISTmAb) and a commercial-sourced polyclonal antibody, both IgG1κ isotype, we apply 2D NMR methods at natural abundance for the acquisition and unbiased statistical analysis of (1)H(N) -(15)N correlated spectra of intact antibody (Ab) and protease-cleaved Fab and Fc fragments. RESULTS: The study demonstrates the feasibility of applying 2D NMR techniques to Abs and the precision with which these methods can be used to map structure and establish comparability between samples at atomic resolution. CONCLUSIONS: The statistical analyses suggests that, within the limit of detection, no significant structural differences are observed between the Fab and Fc domains of each respective intact Ab and its corresponding fragments. Discrimination between dissimilar species, such as between the Fab domains of both Abs or between the glycosylated and deglycosylated Fc domains, was further demonstrated. As such, these methods should find general utility for the assessment of mAb higher order structure.
Entities:
Keywords:
NMR; higher order structure; monoclonal antibody; statistical comparability
Authors: Leszek Poppe; John B Jordan; Ken Lawson; Matthew Jerums; Izydor Apostol; Paul D Schnier Journal: Anal Chem Date: 2013-09-24 Impact factor: 6.986
Authors: Ryan Tullius; Affar S Karimullah; Marion Rodier; Brian Fitzpatrick; Nikolaj Gadegaard; Laurence D Barron; Vincent M Rotello; Graeme Cooke; Adrian Lapthorn; Malcolm Kadodwala Journal: J Am Chem Soc Date: 2015-06-26 Impact factor: 15.419
Authors: Robert G Brinson; Houman Ghasriani; Derek J Hodgson; Kristie M Adams; Ian McEwen; Darón I Freedberg; Kang Chen; David A Keire; Yves Aubin; John P Marino Journal: J Pharm Biomed Anal Date: 2017-04-04 Impact factor: 3.935
Authors: Korth W Elliott; Houman Ghasriani; Mats Wikström; John P Giddens; Yves Aubin; Frank Delaglio; John P Marino; Luke W Arbogast Journal: Anal Chem Date: 2020-04-14 Impact factor: 6.986
Authors: Priscilla Kheddo; Matthew J Cliff; Shahid Uddin; Christopher F van der Walle; Alexander P Golovanov Journal: MAbs Date: 2016-08-11 Impact factor: 5.857